EARNEST Partners
XLRN

EARNEST Partners’s Acceleron Pharma XLRN Stock Holding History

EARNEST Partners’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-47
Closed -$8K – 1221
2021
Q3 		$8K Hold
47
– – ﹤0.01% 733
2021
Q2 		$6K Hold
47
– – ﹤0.01% 828
2021
Q1 		$6K Hold
47
– – ﹤0.01% 819
2020
Q4 		$6K Hold
47
– – ﹤0.01% 786
2020
Q3 		$5K Buy
+47
New +$4.68K ﹤0.01% 794

EARNEST Partners's XLRN Position: Q4 2021 in Review

EARNEST Partners sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 47 shares — an estimated $8K sold.

EARNEST Partners first reported a position in XLRN in Q3 2020 and held it in 5 quarters. The position peaked at $8K in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

  • EARNEST Partners reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
  • EARNEST Partners sold 47 Acceleron Pharma shares in Q4 2021, an estimated $8K.
  • EARNEST Partners first reported a position in Acceleron Pharma in Q3 2020 and held it in 5 quarters.
  • EARNEST Partners's Acceleron Pharma position peaked at $8K in Q3 2021.
  • 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on EARNEST Partners's 13F filing for Q4 2021, filed 7 Feb 2022.